Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 3
2004 2
2006 1
2008 1
2010 1
2011 1
2012 1
2013 1
2014 1
2015 2
2016 2
2017 4
2018 1
2019 2
2020 4
2021 5
2022 4
2023 4
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Metallothionein-3 is a multifunctional driver that modulates the development of sorafenib-resistant phenotype in hepatocellular carcinoma cells.
Rodrigo MAM, Michalkova H, Jimenez AMJ, Petrlak F, Do T, Sivak L, Haddad Y, Kubickova P, de Los Rios V, Casal JI, Serrano-Macia M, Delgado TC, Boix L, Bruix J, Martinez Chantar ML, Adam V, Heger Z. Rodrigo MAM, et al. Among authors: boix l. Biomark Res. 2024 Apr 9;12(1):38. doi: 10.1186/s40364-024-00584-y. Biomark Res. 2024. PMID: 38594765 Free PMC article.
Sensitization of cholangiocarcinoma cells to chemotherapy through BCRP inhibition with β-caryophyllene oxide.
Ortiz-Rivero S, Peleteiro-Vigil A, Abete L, Lozano E, Hammer HS, Giacomo SD, Abad M, Boix L, Forner A, Reig M, Macias RIR, Pötz O, Marin JJG, Briz O. Ortiz-Rivero S, et al. Among authors: boix l. Biomed Pharmacother. 2024 Jan;170:116038. doi: 10.1016/j.biopha.2023.116038. Epub 2023 Dec 22. Biomed Pharmacother. 2024. PMID: 38141281 Free article.
La sobreexpresión de FoxO1 en el hígado esta positivamente asociada al grado de daño hepático en pacientes cirróticos.
Fernández-Galán E, Sandalinas S, Macias-Muñoz L, Portolés I, Ribera J, Morales-Romero B, Pauta M, Casals G, Boix L, Jiménez W, Morales-Ruiz M. Fernández-Galán E, et al. Among authors: boix l. Adv Lab Med. 2023 Aug 4;4(3):227-235. doi: 10.1515/almed-2023-0054. eCollection 2023 Sep. Adv Lab Med. 2023. PMID: 38075172 Free PMC article. Spanish.
Metabolic liver cancer: associations of rare and common germline variants in one-carbon metabolism and DNA methylation genes.
Antwi SO, Heckman M, White L, Yan I, Sarangi V, Lauer KP, Reddy J, Ahmed F, Veliginti S, Mejías Febres ED, Hatia RI, Chang P, Izquierdo-Sanchez L, Boix L, Rojas A, Banales JM, Reig M, Stål P, Gómez MR, Singal AG, Li D, Hassan MM, Roberts LR, Patel T. Antwi SO, et al. Among authors: boix l. Hum Mol Genet. 2023 Aug 7;32(16):2646-2655. doi: 10.1093/hmg/ddad099. Hum Mol Genet. 2023. PMID: 37369012
Polymorphism AGT2 (rs4762) is involved in the development of dermatologic events: Proof-of-concept in hepatocellular carcinoma patients treated with sorafenib.
Sapena V, Iavarone M, Boix L, Facchetti F, Guarino M, Sanduzzi Zamparelli M, Granito A, Samper E, Scartozzi M, Corominas J, Marisi G, Díaz A, Casadei-Gardini A, Gramantieri L, Lampertico P, Morisco F, Torres F, Bruix J, Reig M. Sapena V, et al. Among authors: boix l. World J Hepatol. 2022 Jul 27;14(7):1438-1458. doi: 10.4254/wjh.v14.i7.1438. World J Hepatol. 2022. PMID: 36158918 Free PMC article.
miR-200c-3p, miR-222-5p, and miR-512-3p Constitute a Biomarker Signature of Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma.
de la Cruz-Ojeda P, Schmid T, Boix L, Moreno M, Sapena V, Praena-Fernández JM, Castell FJ, Falcón-Pérez JM, Reig M, Brüne B, Gómez-Bravo MA, Giráldez Á, Bruix J, Ferrer MT, Muntané J. de la Cruz-Ojeda P, et al. Among authors: boix l. Cells. 2022 Aug 28;11(17):2673. doi: 10.3390/cells11172673. Cells. 2022. PMID: 36078082 Free PMC article.
42 results